Lowenstein Sandler represented RTW Investments in the transaction. Jade Biosciences, Inc. (“Jade”) closed its $80 million financing round. The financing was led by RTW Investments, Fairmount...
Jade Biosciences’ $80 Million Financing Round
Oricell Therapeutics’ $45 Million Series B1 Financing
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal. Oricell Therapeutics Co., Ltd, a China-based innovative pharmaceutical company committed to the development of tumor...
Lycia Therapeutics’ $70 Million Series B Financing
Wilson Sonsini Goodrich & Rosati advised RTW Investments on the deal while Fenwick & West represented Lycia Therapeutics. Lycia Therapeutics, Inc., a leader in extracellular protein...